ALXN
Alexion Pharmaceuticals Inc
Price:  
182.50 
USD
Volume:  
15,135,400.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alexion Relative Valuation

-73.6%
Upside

As of 2025-06-15, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 48.12 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -73.6%.

The range of the Relative Valuation is 30.32 - 64.10 USD.

Range Selected
Trailing P/E multiples 14.7x - 20.8x 18.2x
Forward P/E multiples 11.7x - 20.6x 15.4x
Fair Price 30.32 - 64.10 48.12
Upside -83.4% - -64.9% -73.6%
182.50 USD
Stock Price
48.12 USD
Fair Price

Alexion Relative Valuation - Historical P/E Data

Date P/E